TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/5/23 16:30 | 1/3/23 | IMGO | Imago Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Arenberg Michael | CA | O | See Rema | M.d | 33 | 15.45 | 0 | 2 | 4 | 52 | D | ||||||||||||||
12/29/22 16:06 | 12/27/22 | IMGO | Imago Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Arenberg Michael | CA | O | See Rema | M.d | 1,667 | 17.55 | 0 | 95 | 49 | D | |||||||||||||||
12/29/22 16:06 | 12/27/22 | IMGO | Imago Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Arenberg Michael | CA | O | See Rema | S.d | -2,533 | 35.93 | 0 | -71 | -59 | 49 | D | ||||||||||||||
12/20/22 16:18 | 12/16/22 | IMGO | Imago Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Arenberg Michael | CA | O | See Rema | M.d | 1,122 | 15.45 | 0 | 73 | 25 | D | |||||||||||||||
12/20/22 16:18 | 12/16/22 | IMGO | Imago Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Arenberg Michael | CA | O | See Rema | S.d | -1,709 | 35.78 | 0 | -48 | -66 | 25 | D | ||||||||||||||
3/13/19 20:03 | 3/12/19 | DRRX | Durect Corp | DE | Health | Drug | Pharmaceutical Preparations | Arenberg Michael | CA | O | CFO | P | 8 | 0.7990 | 0 | 10 | 69 | 24 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |